Plasma levels of D-dimer and circulating endothelial adhesion molecules in veno-occlusive disease of the liver following allogeneic bone marrow transplantation

European Journal of Haematology

Volumn 60, Issue 2, 1998, Pages 106-111

  Südhoff, Thomas ^a   Heins, Michael ^a   Söhngen, Dietmar ^a   Lenz, Viola ^a   Wehmeier, Artur ^a   Aul, Carlo ^a   Meckenstock, Gerald ^a   Schneider, Wolfgang ^a   Reinauer, Hans ^a   Heyll, Axel ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Allogeneic BMT; D dimer; E selectin; ICAM 1; VCAM 1; VOD

Indexed keywords

ALTEPLASE; BILIRUBIN; CYCLOSPORIN A; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ETOPOSIDE; FIBRIN; INTERCELLULAR ADHESION MOLECULE 1; METHOTREXATE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FIBRINOLYSIS; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA; LIVER VENOOCCLUSIVE DISEASE; MALE; MULTIPLE ORGAN FAILURE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

EID: 14444288022     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01006.x     Document Type: Article

References (38)

1. SHULMAN HM, HINTERBERGER W. Hepatic veno-occulsive disease - liver toxicity syndrome after bone marrow transplantation. Transplantation 1992: 10: 197-214.
2. BEARMAN SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995: 85: 3005-3020.
3. RODENHUIS S, WESTERMANN A, HOLTKAMP MJ, et al. Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer. J Clin Oncol 1996: 14: 1473-1483.
4. JONES RJ, LEE KSK, BESCHORNER WE, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987: 44: 778-783.
5. MCDONALD GB, SHARMA P, MATTHEWS DE, SHULMAN HM, THOMAS ED. The clinical course of 53 patients with venoocclusive disease of the liver after marrow transplantation. Transplantation 1985: 39: 603-608.
6. MCDONALD GB, HINDS MS, LLOYD D, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993: 118: 255-267.
7. ROZMAN C, CARRERAS E, QIAN C, et al. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Trans 1996: 17: 75-80.
8. MCDONALD GB, HINDS M, FISHER L, SCHOCH HG. Liver toxicity following cytoreductive therapy for marrow transplantation: risk factors, incidence, and outcome. Hepatology 1991: 14: 162A (459).
9. DIX SP, WINGARD JR, MULLINS RE, et al. Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Trans 1996: 17: 225-230.
10. CATANI L, GUGLIOTTA L, VIANELLI N, et al. Endothelium and bone marrow transplantation. Bone Marrow Trans 1996: 17: 277-280.
11. RINGDEN O, WENNBERG L, ERICZON BG, et al. Alteplase for hepatic veno-occlusive disease after bone marrow transplantation. Lancet 1992: 340: 546-547.
12. BARGLIN TP, HARPER P, MARCUS RE. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator. Bone Marrow Trans 1990: 5: 439-441.
13. BEARMAN SI, LEE JL, BARON AE, MCDONALD GB. Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen acitivator and heparin in 42 marrow transplant patients. Blood 1997: 89: 1501-1506.
14. CARLOS TM, HARLAN JM. Leukocyte-endothelial adhesion molecules. Blood 1994: 84: 2068-2101.
15. PIGOTT R, DILLON LP, HEMINGWAY IH, GEARING AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Comm 1992: 2: 584-589.
16. SCHLOSSMAN SF, BOUMSELL L, GILKS W, et al. CD antigens 1993. Immunol Today 1994: 15: 98-99.
17. BOUNAMEAUX H, DE MOERLOOSE P, PERRIER A, REBER G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 1994: 71: 1-6.
18. VAN BEEK EJR, SCHENK BE, MICHEL BC, et al. The role of plasma D-dimer concentration in the exclusion of pulmonary embolism. Br J Haematol 1996: 92: 725-732.
19. ATTAL M, HUGUET F, RUBIE H, et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. Blood 1992: 79: 2834-2840.
20. THOMAS ED, STORB R, CLIFT RA, et al. Bone Marrow Transplantation. N Engl J Med 1975: 43: 895-902.
21. BEARMAN SI, ANDERSON GL, MORI M, HINDS MS, SHULMAN HM, MCDONALD GB. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993: 11: 1729-1736.
22. SPRINGER TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994: 76: 301-314.
23. BEVILACQUA MP, POBER JS, MENDRICK DL, COTRAN RS, GIMBRONE MA JR. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987: 84: 9238-9242.
24. OSBORN L, HESSION C, TIZARD R, et al. Direct expression cloning of a vascular cell adhesion molecule-1 (VCAM-1), a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989: 59: 1203-1211.
25. SIMMONS PJ, MASINOVSKY B, LONGENECKER BM, BERENSON R, TOROK-STORB B, GALLATIN W. Vascular cell adhesion molecule-1 expressed by bone marrow stroma cells mediates the binding of hematopoietic progenitor cells. Blood 1992: 80: 388-395.
26. HOLLER E, KOLB H, MOLLER A, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990: 75: 1011-1016.
27. REMBERGER M, RINGDEN O. Increased levels of soluble interleukin-2 receptor in veno-occulusive disease of the liver after allogeneic bone marrow transplantation. Transplantation 1995: 60: 1293-1299.
28. RACADOT E, CAHN JY, BRION A, VOILLAT E, PLOUVIER E, HERVE P. Cytokines, cytokine receptors and adhesion molecules after allogeneic bone marrow transplantation. Bone Marrow Trans 1994; (suppl 1): 107.
29. SÜDHOFF T, WEHMEIER A, ARNING M, BAUSER U, SCHLÖMER P, SCHNEIDER W. Pneumonia during chemotherapy-induced neutropenia is associated with increase of sICAM-1 plasma levels. Leukemia 1997: 11: 346-351.
30. DUSTIN ML, ROTHLEIN R, BHAN AK, DINARELLO CA, SPRINGER TA. Induction by IL 1 and interferon-γ, tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986: 137: 245-254.
31. COLLINS P, RODERICK A, O'BRIEN D, et al. Factor VIIa and other haemostatic variables following bone marrow transplantation. Thromb Haemost 1994: 72: 28-32.
32. GORDON B, HAIRE W, KESSINGER A, DUGGAN M, ARMITAGE J. High frequency of antithrombin III and protein C deficiency following autologous bone marrow transplantation for lymphoma. Bone Marrow Trans 1991: 8: 497-502.
33. SCROBOHACHI MI, DROUET L, MONEMMASHI A, et al. Liver venoocclusive disease after bone marrow transplantation: changes in coagulation parameters and endothelial markers. Thromb Res 1991: 63: 509-519.
34. HARPER PL, JARVIS J, JENNINGS I, LUDDINGTON R, MARCUS RE. Changes in the natural anticoagulants following bone marrow transplantation. Bone Marrow Trans 1990: 5: 39-42.
35. FAIONI EM, KRACHMALNICOFF A, BEARMAN SI, et al. Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver. Blood 1993: 81: 3458-3462.
36. SALAT C, HOLLER E, REINHARDT B, et al. Hyperkoagulabilität bei Patienten mit venookklusiver Erkrankung nach Knochenmarktransplantation. Med Klin 1994: 89: 245-247.
37. CATANI L, GUGLIOTTA M, MATTIOLI BELMONTE N, et al. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies. Transplantation 1993: 12: 253-259.
38. BECKER DM, PHILBRICK JT, BACHHUBER TL, HUMPHRIES JE. D-dimer testing and acute venous thromboembolism - a shortcut to accurate diagnosis? Arch Intern Med 1996: 156: 939-946.